<DOC>
	<DOCNO>NCT02691429</DOCNO>
	<brief_summary>Our research group test toxicity different dye concentration extract acai fruit use rabbit model . The dye extract acai fruit concentration 10 % 25 % find safe vitreoretinal surgery . This initial research represent landmark research test alternative vital dye clinical research human . The aim present clinical trial human test applicability acai dye identification posterior hyaloid ILM vitreoretinal surgery human .</brief_summary>
	<brief_title>Applicability Acai Fruit ( Euterpe Oleracea ) Dye Chromovitrectomy Humans</brief_title>
	<detailed_description>The purpose present clinical trial human test impregnation capacity acai dye ( 10 25 % concentration ) identification posterior hyaloid ILM vitreoretinal surgery human . Twenty-four patient seek treatment Ophthalmology Department The Federal University São Paulo select study . Inclusion criteria patient diagnosed epiretinal membrane , macular hole diabetic retinopathy ( without vitreal hemorrhage , and/or macular edema , and/or vitreomacular traction ) . All must indicate vitrectomy surgery removal epiretinal membrane and/or internal limit membrane . The present clinical trial approve ethic committee Federal University São Paulo ( CEP-UNIFESP ) . All patient invite sign Informed Consent Form participate study . Twenty-four different retina surgeon operate one 24 select patient , use standard vitrectomy technique employ 4 sclerotomy 23-gauge system accessory illumination . All surgery perform use acai dye ( Euterpe oleracea ) follow concentration : 10 % ( n=12 ) 25 % ( n=12 ) . Immediately procedure , surgeon give evaluation questionnaire fill-in . All patient submit follow routine pre-operatory evaluation : 1 . Physical pre-anesthesia evaluation - perform Anesthesiology Team São Paulo Hospital . 2 . Complete Ophthalmological Examination - include : 1 . Visual Acuity Measurements best correction eye . 2 . Applaination Tonometry ( Goldman Tonometer ) . For , one drop anesthetic solution one drop fluorescein instill eye . 3 . Biomicroscopy 4 . Indirect binocular ophthalmoscopy : mydriasis obtain procedure topical application tropicamide phenylephrine . 5 . Retinography Angiofluoresceinography ( patient mydriasis- except `` opacidade de meios '' ) 6 . Optical Coherence Tomography ( OCT ) posterior segment ( except `` opacidade de meios '' ) 7 . Multifocal Electroretinogram ( except `` opacidade de meios '' ) The vitrectomy surgery perform patient present study use 23-gauge technique compose 4 sclerectomies vitrectomy without 23-gauge suture . During surgery , vitreous removal , dye extract acai fruit slowly inject use 23 25-gauge silicone cannula connect 5ml syringe . The objective slow injection dye deposit posterior hyloid/peripheral vitreous due gravity . At moment , photographic documentation perform . After dislocation posterior hyloid , removal peripheral vitreous excess dye , MachemerTM ( Volk , Germany ) macula magnify lens use improve visualization removal ILM use intraocular tweezer . If ILM visible , second injection dye perform . At end surgery , patient receive medical prescription drop antibiotic corticoid association 1 week procedure , follow vitrectomy post-surgical routine . A questionnaire 6 question ( ANNEX 1 ) hand surgeon end surgery .</detailed_description>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Retinal Perforations</mesh_term>
	<mesh_term>Epiretinal Membrane</mesh_term>
	<criteria>Diagnosed epiretinal membrane , macular hole proliferative diabetic retinopathy ( without vitreous hemorrhage ) . Indicated surgical removal epiretinal memebrane ( without removal internal limit membrane ) . Previous ocular pathology Glaucoma Any previous ocular infection would modify ocular anatomy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Vitreoretinal surgery</keyword>
	<keyword>euterpe oleracea</keyword>
	<keyword>chromovitrectomy</keyword>
</DOC>